Clinical Trials Logo

Clinical Trial Summary

The rapid spread and increase of acute respiratory infection cases caused by the novel SARS-CoV-2 coronavirus represent a major challenge for healthcare systems around the world. The shortage of facilities and medical personnel is a major problem in the face of a serious epidemic. The Lombardy Region, and in particular the territories of Milan, Bergamo and Brescia, was the most affected due to the rapid increase in cases and limited medical resources during the initial phase of the epidemic. The collaboration between hospital and territory with integrated communication systems and the monitoring of patients with appropriate technological tools that include telemedicine, are fundamental to ensure the continuity of care and the sustainability of the health system, also significantly reducing the risk of contagion for health professionals.


Clinical Trial Description

The MIRATO Project wants to test the remote health surveillance services and a telemonitoring program for patients discharged after a period of hospitalization for COVID19 caused by the new coronavirus SARS-CoV-2 and their comorbidities if present. Patients discharged from hospitals still present in many cases breathing difficulties, bed rest symptoms and other disabilities related to the acute event. In addition, some patients are seeing rekindling of symptoms such as fever, dry cough, difficulty respiratory and blood desaturation into oxygen. These problems underline the need for procedures that allow us to safely discharge patients to be able to better follow their convalescence but also to be able to intervene quickly in the event of symptoms returning. The purpose of the home health surveillance intervention will be: - Monitor the evolution of the state of health with standardized tools based on scientific evidence - Provide counselling support to help recovery - Have certain and early identification of signs and symptoms related to a possible resumption of the COVID19 pathology and or to comorbidities - Compare outcome results with case-control design three months after hospital discharge ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04898179
Study type Observational
Source Istituti Clinici Scientifici Maugeri SpA
Contact
Status Completed
Phase
Start date November 1, 2020
Completion date January 16, 2022